Pinnacle Associates
EW icon

Pinnacle Associates’s Edwards Lifesciences EW Stock Holding History

Pinnacle Associates’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$643K Buy
7,451
+80
+1% +$7.11K 0.01% 624
2026
Q2 		$667K Buy
7,371
+219
+3% +$18.3K 0.01% 623
2026
Q1 		$573K Buy
7,152
+126
+2% +$10.4K 0.01% 628
2025
Q4 		$599K Buy
7,026
+2,081
+42% +$171K 0.01% 615
2025
Q3 		$385K Sell
4,945
-177
-3% -$13.8K 0.01% 693
2025
Q2 		$401K Buy
5,122
+810
+19% +$60.4K 0.01% 676
2025
Q1 		$313K Sell
4,312
-167
-4% -$12K ﹤0.01% 706
2024
Q4 		$332K Sell
4,479
-1,056
-19% -$73.9K ﹤0.01% 691
2024
Q3 		$422K Sell
5,535
-178
-3% -$12.9K 0.01% 604
2024
Q2 		$528K Sell
5,713
-5
-0.1% -$443 0.01% 575
2024
Q1 		$546K Buy
5,718
+183
+3% +$15.4K 0.01% 569
2023
Q4 		$422K Sell
5,535
-193
-3% -$13.4K 0.01% 612
2023
Q3 		$397K Sell
5,728
-598
-9% -$48.1K 0.01% 597
2023
Q2 		$597K Buy
6,326
+248
+4% +$21.6K 0.01% 553
2023
Q1 		$503K Buy
6,078
+795
+15% +$62.5K 0.01% 517
2022
Q4 		$394K Buy
5,283
+336
+7% +$25.9K 0.01% 554
2022
Q3 		$409K Buy
4,947
+168
+4% +$16.2K 0.01% 534
2022
Q2 		$454K Buy
4,779
+971
+25% +$101K 0.01% 535
2022
Q1 		$448K Buy
+3,808
New +$427K 0.01% 585
2020
Q1 		– Sell
-3,285
Closed -$255K – 678
2019
Q4 		$255K Hold
3,285
– – 0.01% 633
2019
Q3 		$241K Buy
+3,285
New +$231K 0.01% 634
2019
Q1 		– Sell
-5,055
Closed -$258K – 718
2018
Q4 		$258K Hold
5,055
– – 0.01% 601
2018
Q3 		$293K Hold
5,055
– – 0.01% 606
2018
Q2 		$245K Hold
5,055
– – 0.01% 626
2018
Q1 		$235K Buy
+5,055
New +$220K ﹤0.01% 610

Other funds holding EW

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mirova US
Mirova US Boston, Massachusetts $9.15B AUM 21.91% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Pinnacle Associates's EW Position: Q3 2026 in Review

Pinnacle Associates increased its Edwards Lifesciences (EW) stake by 1.1% in Q3 2026, buying an estimated $7.11K and bringing the position to 7,451 shares worth $643K. The position accounts for 0.01% of the portfolio, ranked #624.

Pinnacle Associates first reported a position in EW in Q1 2018 and has held it in 25 quarters since. The position peaked at $667K in Q2 2026. 719 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Pinnacle Associates held 7,451 shares of Edwards Lifesciences worth $643K as of Q3 2026.
  • Pinnacle Associates bought 80 Edwards Lifesciences shares in Q3 2026, an estimated $7.11K.
  • Edwards Lifesciences made up 0.01% of Pinnacle Associates's portfolio in Q3 2026, its #624 holding.
  • Pinnacle Associates first reported a position in Edwards Lifesciences in Q1 2018 and has held it in 25 quarters since.
  • Pinnacle Associates's Edwards Lifesciences position peaked at $667K in Q2 2026.
  • 719 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Pinnacle Associates's 13F filing for Q3 2026, filed 20 Oct 2026.